Name: 글로벌 시장 동향
SKU: MD62
Availability: InStock

보고서 요약(국문)

개요
전 세계 위험 약물 투여 시장은 2023년 YY백만 달러에 도달했으며, 2024년부터 2031년까지 연평균 성장률(CAGR) YY%로 성장하여 2031년에는 YY백만 달러에 이를 것으로 예상됩니다.
위험 약물 투여는 고유한 독성, 발암성, 기형 유발성, 생식 독성 또는 인체 건강과 환경에 해로운 기타 특성으로 인해 위험하다고 간주되는 약물을 취급, 조제, 투약 및 투여하는 과정입니다. 항암제, 면역억제제, 항바이러스제, 호르몬제 및 일부 생물학적 제제가 이러한 약물에 해당합니다.
위험 약물 투여 중 환자의 안전을 보장하기 위해서는 정확한 용량 투여, 부작용 모니터링 및 치료 기준 준수가 필수적입니다. 의료진은 처방 오류 및 위험 반응 발생 가능성을 줄이기 위해 확립된 절차를 준수해야 합니다.

시장 동향: 성장 동력 및 제약 요인
직업적 위험에 대한 인식 증가
직업적 위험에 대한 인식이 높아짐에 따라 시장 성장이 촉진될 것으로 예상됩니다. 의료 전문가들이 유해 의약품 노출의 잠재적 위험성을 더 잘 인지하게 되면서, 이러한 위험을 줄이는 안전 조치에 대한 수요가 증가하고 있습니다. 결과적으로 의료 시설에서는 밀폐형 이송 장치(CSTD), 음압실, 개인 보호 장비(PPE) 및 적절한 환기 시스템에 대한 수요가 증가할 것입니다.
규제 기관과 의료 기관은 의료 종사자를 직업적 위험으로부터 보호하는 데 더욱 집중하고 있습니다. 이는 유해 의약품 취급에 대한 법규 및 절차를 강화하고, 안전한 투여를 보장하는 기술 및 장비에 대한 수요를 촉진합니다.
직업적 위험에 대한 인식이 높아짐에 따라 의료진을 위한 안전한 약물 취급 절차에 대한 교육 프로그램의 필요성이 증가하고 있습니다. 이는 교육 모듈, 교육 자료, 그리고 유해 의약품 안전에 특화된 전문 교육 기관에 대한 시장 성장을 촉진합니다. 따라서 위의 요인들이 시장 성장을 견인할 것으로 예상됩니다.

밀폐형 약물 이송 장치(CSTD)의 높은 비용
밀폐형 약물 이송 장치는 의료진의 유해 약물 노출을 줄이기 위한 특수 도구입니다. 안전성을 크게 향상시키지만, CSTD는 구매 및 설치 비용이 높아 일부 의료 시설, 특히 저소득 및 중소득 국가에서는 사용이 제한될 수 있습니다.
세분화 분석
전 세계 유해 약물 투여 시장은 시스템, 약물 유형, 장치, 약물 형태 및 지역별로 세분화됩니다.
밀폐형 약물 이송 장치(CSTD) 부문이 시장 성장을 주도할 것으로 예상됩니다.
밀폐형 약물 이송 장치(CSTD)는 여러 가지 중요한 이점과 안전에 대한 규제 강화 추세로 인해 유해 약물 투여 시장을 주도할 것으로 예상됩니다. CSTD는 약물 준비, 투여 및 폐기 과정에서 의료진과 수의사의 유해 약물 노출을 줄이기 위해 고안되었습니다. 밀폐된 연결부와 차단막은 약물 증기나 에어로졸의 누출을 방지하여 흡입이나 피부 접촉의 위험을 낮춥니다.

의료진과 환자를 보호하기 위해 미국 식품의약국(FDA)과 유럽의약품청(EMA)과 같은 규제 기관은 위험 약물 취급에 대한 엄격한 기준을 마련하고 있습니다. 이러한 지침 중 상당수는 안전 기준 준수를 보장하기 위해 폐쇄형 약물 이송 장치(CSTD) 사용을 권장하거나 의무화하고 있습니다.
지역 분석
북미는 위험 약물 투여 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
북미는 선진적인 의료 인프라, 높은 만성 질환 발병률, 그리고 기술 혁신으로 인해 위험 약물 투여 시장에서 주도적인 위치를 차지할 것으로 예상됩니다.
북미는 탄탄한 병원 시스템, 진료소, 동물병원 등 잘 발달된 의료 인프라를 갖추고 있습니다. 이러한 기관들은 환자 안전과 의료진 안전을 최우선으로 생각하며, 보다 안전한 약물 투여를 위해 폐쇄형 약물 이송 장치(CSTD) 및 생물학적 안전 캐비닛(BSC)과 같은 기술에 상당한 투자를 해왔습니다.
이 지역에서는 암, 자가면역 질환, 바이러스성 질환이 흔하며, 이러한 질환 치료를 위해 항암제 및 면역억제제와 같은 위험 약물을 사용하는 경우가 많습니다. 이는 의료 및 수의학 분야에서 위험한 약물 투여 절차가 널리 사용되고 있음을 의미합니다. 따라서 위의 요인들이 해당 지역을 지배적인 위치로 유지할 것으로 예상됩니다.
시장 세분화
시스템별
• 밀폐형
• 개방형
약물 유형별
• 위험 약물
• 항유사분열제
장치별
• 루어 락
• 클릭 투 락
• 푸시-턴-푸시
• 색상 정렬
• 기타
약물 형태별
• 액체
• 고체
약물 형태별
• 중력식
• 펌프식
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 ICU Medical, Equashield, LLC, Simplivia Healthcare Ltd., Becton & Dickinson, Baxter 등이 있습니다. 주요 기업으로는 International, Vygon SAS, JMS Co., Ltd., B. Braun Medical Inc., Yukon Medical, Codan Medical 등이 있습니다.

보고서 구매 이유:

• 시스템, 약물 유형, 기기, 약물 형태 및 지역별 글로벌 위험 약물 투여 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 위험 약물 투여 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 위험 약물 투여 시장 보고서는 약 53개의 표, 47개의 그림, 176페이지로 구성됩니다.
2023년 주요 고객
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global hazardous drug administration market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
Hazardous drug administration is the process of handling, preparing, dispensing, and administering medications that are considered hazardous due to their inherent toxicity, carcinogenicity, teratogenicity, reproductive toxicity, or other properties that harm human health and the environment. Chemotherapy agents, immunosuppressants, antivirals, hormones, and some biological agents are among the medications available.
Ensuring patient safety during hazardous drug administration entails precise dosing, monitoring for side effects, and adhering to treatment standards. Healthcare practitioners must adhere to established processes to reduce the likelihood of prescription errors and hazardous reactions.
Market Dynamics: Drivers & Restraints
Growing Awareness of Occupational Hazards
Growing awareness of occupational hazards is expected to drive the market growth. As healthcare professionals become more aware of the potential risks of exposure to hazardous medications, there is a greater demand for safety measures that reduce such hazards. As a result, healthcare facilities will require more closed system transfer devices (CSTDs), negative pressure rooms, personal protective equipment (PPE), and suitable ventilation systems.
Regulatory organizations and healthcare institutions are focusing more on protecting healthcare workers from occupational dangers. This leads to more difficult laws and procedures for dealing with dangerous pharmaceuticals, which drives the demand for technology and equipment that assure safe administration.
The increased awareness of occupational hazards needs improved training and education programs for healthcare personnel on safe drug handling procedures. This fuels the market for training modules, educational materials, and even specialist training institutions focused on hazardous drug safety. Thus, the above factors are expected to drive the market growth.
High cost of Closed System Transfer Devices (CSTDs)
Closed system transfer devices serve as specialized tools for reducing healthcare personnel' exposure to hazardous medications. While they considerably improve safety, CSTDs can be costly to purchase and implement, thereby limiting their use in some healthcare facilities, particularly in low- and middle-income nations.
Segment Analysis
The global hazardous drug administration market is segmented based on systems, drug type, devices, drug form, and region.
Closed-System Drug Transfer Devices (CSTDs) segment is expected to dominate the market growth
Closed-system drug transfer devices (CSTDs) are likely to dominate the hazardous drug administration market due to several significant advantages and an increased regulatory focus on safety. CSTDs are intended to reduce the exposure of healthcare workers and veterinarians to hazardous medications during preparation, delivery, and disposal. Airtight connections and barriers prevent drug vapors or aerosols from escaping, lowering the danger of inhalation or skin contact.
To protect healthcare personnel and patients, regulatory bodies such as the United States Food and Drug Administration and the European Medicines Agency (EMA) have rigorous standards for handling dangerous medications. Many of these guidelines encourage or require the use of CSTDs to guarantee compliance with safety standards.
Geographical Analysis
North America is expected to hold a significant position in the hazardous drug administration market share
North America is expected to hold a dominant position in the hazardous drug administration market due to the advanced healthcare infrastructure in the region, high incidence of chronic diseases, and technological innovation.
North America has a well-developed healthcare infrastructure, including robust hospital systems, clinics, and veterinary facilities. These institutions prioritize patient safety and healthcare worker safety, which has resulted in considerable investments in technologies such as closed-system drug transfer devices (CSTDs) and biological safety cabinets (BSCs) for safer medication administration.
Cancer, autoimmune disorders, and viral diseases are common in the region, necessitating the use of hazardous medications such as chemotherapeutic agents and immunosuppressants for treatment. This involves widespread usage of hazardous medication administration procedures in the healthcare and veterinary sectors. Thus, the above factors are expected to hold the region in the dominant position.
Market Segmentation
By Systems
• Closed
• Non-Closed
By Drug Type
• Hazardous Drugs
• Antimitotics
By Devices
• Luer Lock
• CLick-to-Lock
• Push-Turn-Push
• Color-to-Color Alignment
• Others
By Drug Form
• Liquid
• Solid
By Drug Form
• Gravity
• Pump
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include ICU Medical, Equashield, LLC, Simplivia Healthcare Ltd., Becton & Dickinson, Baxter International, Vygon SAS, JMS Co., Ltd., B. Braun Medical Inc., Yukon Medical, and Codan Medical among others.
Why Purchase the Report?
• To visualize the global hazardous drug administration market segmentation based on systems, drug type, devices, drug form, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of hazardous drug administration market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global hazardous drug administration market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Systems
3.2. Snippet by Drug Type
3.3. Snippet by Devices
3.4. Snippet by Drug Form
3.5. Snippet by Perfusion Pressure
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Ri Growing Awareness of Occupational Hazards
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. High cost of closed system transfer devices (CSTDs)
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Systems
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Systems
6.1.2. Market Attractiveness Index, By Systems
6.2. Closed*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Closed
7. By Drug Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
7.1.2. Market Attractiveness Index, By Drug Type
7.2. Hazardous Drugs*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Antimitotic Drugs
8. By Devices
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
8.1.2. Market Attractiveness Index, By Devices
8.2. Luer Lock*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. CLick-to-Lock
8.4. Push-Turn-Push
8.5. Color-to-Color Alignment
8.6. Others
9. By Drug Form
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Form
9.1.2. Market Attractiveness Index, By Drug Form
9.2. Liquid*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Solid
10. By Perfusion Pressure
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Perfusion Pressure
10.1.2. Market Attractiveness Index, By Perfusion Pressure
10.2. Gravity*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pump
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Systems
11.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
11.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
11.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Form
11.2.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Perfusion Pressure
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.3.1. U.S.
11.2.3.2. Canada
11.2.3.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Systems
11.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
11.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Form
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.4.1. Germany
11.3.4.2. UK
11.3.4.3. France
11.3.4.4. Italy
11.3.4.5. Spain
11.3.4.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Systems
11.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
11.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Form
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.4.1. Brazil
11.4.4.2. Argentina
11.4.4.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Systems
11.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
11.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Form
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.4.1. China
11.5.4.2. India
11.5.4.3. Japan
11.5.4.4. Australia
11.5.4.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Systems
11.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
11.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Devices
11.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Form
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. ICU Medical*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Equashield, LLC
13.3. Simplivia Healthcare Ltd.
13.4. Becton & Dickinson
13.5. Baxter International
13.6. Vygon SAS
13.7. JMS Co., Ltd.
13.8. B. Braun Medical Inc.
13.9. Yukon Medical
13.10. Codan Medical
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

ICU Medical, 4.	Key Developments, Equashield, LLC, Simplivia Healthcare Ltd., Becton & Dickinson, Baxter International, Vygon SAS, JMS Co., Ltd., B. Braun Medical Inc., Yukon Medical, Codan Medical

표 목록 (Tables)

List of Tables

Table 1 Global Hazardous Drug Administration Market Value, By Systems, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Hazardous Drug Administration Market Value, By Drug Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Hazardous Drug Administration Market Value, By Devices, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Hazardous Drug Administration Market Value, By Drug Form, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Hazardous Drug Administration Market Value, By Perfusion Pressure, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Hazardous Drug Administration Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Hazardous Drug Administration Market Value, By Systems, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Hazardous Drug Administration Market Value, By Systems, 2022-2031 (US$ Million)

Table 9 Global Hazardous Drug Administration Market Value, By Drug Type, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Hazardous Drug Administration Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 11 Global Hazardous Drug Administration Market Value, By Devices, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Hazardous Drug Administration Market Value, By Devices, 2022-2031 (US$ Million)

Table 13 Global Hazardous Drug Administration Market Value, By Drug Form, 2023, 2027 & 2031 (US$ Million)

Table 14 Global Hazardous Drug Administration Market Value, By Drug Form, 2022-2031 (US$ Million)

Table 15 Global Hazardous Drug Administration Market Value, By Perfusion Pressure, 2023, 2027 & 2031 (US$ Million)

Table 16 Global Hazardous Drug Administration Market Value, By Perfusion Pressure, 2022-2031 (US$ Million)

Table 17 Global Hazardous Drug Administration Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 18 Global Hazardous Drug Administration Market Value, By Region, 2022-2031 (US$ Million)

Table 19 North America Hazardous Drug Administration Market Value, By Systems, 2022-2031 (US$ Million)

Table 20 North America Hazardous Drug Administration Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 21 North America Hazardous Drug Administration Market Value, By Devices, 2022-2031 (US$ Million)

Table 22 North America Hazardous Drug Administration Market Value, By Drug Form, 2022-2031 (US$ Million)

Table 23 North America Hazardous Drug Administration Market Value, By Perfusion Pressure, 2022-2031 (US$ Million)

Table 24 North America Hazardous Drug Administration Market Value, By Country, 2022-2031 (US$ Million)

Table 25 South America Hazardous Drug Administration Market Value, By Systems, 2022-2031 (US$ Million)

Table 26 South America Hazardous Drug Administration Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 27 South America Hazardous Drug Administration Market Value, By Devices, 2022-2031 (US$ Million)

Table 28 South America Hazardous Drug Administration Market Value, By Drug Form, 2022-2031 (US$ Million)

Table 29 South America Hazardous Drug Administration Market Value, By Perfusion Pressure, 2022-2031 (US$ Million)

Table 30 South America Hazardous Drug Administration Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Europe Hazardous Drug Administration Market Value, By Systems, 2022-2031 (US$ Million)

Table 32 Europe Hazardous Drug Administration Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 33 Europe Hazardous Drug Administration Market Value, By Devices, 2022-2031 (US$ Million)

Table 34 Europe Hazardous Drug Administration Market Value, By Drug Form, 2022-2031 (US$ Million)

Table 35 Europe Hazardous Drug Administration Market Value, By Perfusion Pressure, 2022-2031 (US$ Million)

Table 36 Europe Hazardous Drug Administration Market Value, By Country, 2022-2031 (US$ Million)

Table 37 Asia-Pacific Hazardous Drug Administration Market Value, By Systems, 2022-2031 (US$ Million)

Table 38 Asia-Pacific Hazardous Drug Administration Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 39 Asia-Pacific Hazardous Drug Administration Market Value, By Devices, 2022-2031 (US$ Million)

Table 40 Asia-Pacific Hazardous Drug Administration Market Value, By Drug Form, 2022-2031 (US$ Million)

Table 41 Asia-Pacific Hazardous Drug Administration Market Value, By Perfusion Pressure, 2022-2031 (US$ Million)

Table 42 Asia-Pacific Hazardous Drug Administration Market Value, By Country, 2022-2031 (US$ Million)

Table 43 Middle East & Africa Hazardous Drug Administration Market Value, By Systems, 2022-2031 (US$ Million)

Table 44 Middle East & Africa Hazardous Drug Administration Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 45 Middle East & Africa Hazardous Drug Administration Market Value, By Devices, 2022-2031 (US$ Million)

Table 46 Middle East & Africa Hazardous Drug Administration Market Value, By Drug Form, 2022-2031 (US$ Million)

Table 47 Middle East & Africa Hazardous Drug Administration Market Value, By Perfusion Pressure, 2022-2031 (US$ Million)

Table 48 ICU Medical : Overview

Table 49 ICU Medical : Product Portfolio

Table 50 ICU Medical : Key Developments

Table 51 Equashield, LLC: Overview

Table 52 Equashield, LLC: Product Portfolio

Table 53 Equashield, LLC: Key Developments

Table 54 Simplivia Healthcare Ltd. : Overview

Table 55 Simplivia Healthcare Ltd. : Product Portfolio

Table 56 Simplivia Healthcare Ltd. : Key Developments

Table 57 Becton & Dickinson : Overview

Table 58 Becton & Dickinson : Product Portfolio

Table 59 Becton & Dickinson : Key Developments

Table 60 Baxter International: Overview

Table 61 Baxter International: Product Portfolio

Table 62 Baxter International: Key Developments

Table 63 Vygon SAS : Overview

Table 64 Vygon SAS : Product Portfolio

Table 65 Vygon SAS : Key Developments

Table 66 JMS Co., Ltd. : Overview

Table 67 JMS Co., Ltd. : Product Portfolio

Table 68 JMS Co., Ltd. : Key Developments

Table 69 B. Braun Medical Inc. : Overview

Table 70 B. Braun Medical Inc. : Product Portfolio

Table 71 B. Braun Medical Inc. : Key Developments

Table 72 Yukon Medical: Overview

Table 73 Yukon Medical: Product Portfolio

Table 74 Yukon Medical: Key Developments

Table 75 Codan Medical: Overview

Table 76 Codan Medical: Product Portfolio

Table 77 Codan Medical: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 2 Global Hazardous Drug Administration Market Share, By Systems, 2023 & 2031 (%)

Figure 3 Global Hazardous Drug Administration Market Share, By Drug Type, 2023 & 2031 (%)

Figure 4 Global Hazardous Drug Administration Market Share, By Devices, 2023 & 2031 (%)

Figure 5 Global Hazardous Drug Administration Market Share, By Drug Form, 2023 & 2031 (%)

Figure 6 Global Hazardous Drug Administration Market Share, By Perfusion Pressure, 2023 & 2031 (%)

Figure 7 Global Hazardous Drug Administration Market Share, By Region, 2023 & 2031 (%)

Figure 8 Global Hazardous Drug Administration Market Y-o-Y Growth, By Systems, 2023-2031 (%)

Figure 9 Closed Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 10 Non-Closed Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 11 Global Hazardous Drug Administration Market Y-o-Y Growth, By Drug Type, 2023-2031 (%)

Figure 12 Hazardous Drugs Drug Type in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 13 Antimitotic Drugs Drug Type in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 14 Global Hazardous Drug Administration Market Y-o-Y Growth, By Devices, 2023-2031 (%)

Figure 15 Luer Lock Devices in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 16 CLick-to-Lock Devices in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 17 Push-Turn-Push Devices in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 18 Color-to-Color Alignment Devices in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 19 Others Devices in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 20 Global Hazardous Drug Administration Market Y-o-Y Growth, By Drug Form, 2023-2031 (%)

Figure 21 Liquid Drug Form in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 22 Solid Drug Form in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 23 Global Hazardous Drug Administration Market Y-o-Y Growth, By Perfusion Pressure, 2023-2031 (%)

Figure 24 Gravity Perfusion Pressure in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 25 Pump Perfusion Pressure in Global Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 26 Global Hazardous Drug Administration Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 27 North America Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 29 Europe Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 30 South America Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 32 North America Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 33 North America Hazardous Drug Administration Market Share, By Systems, 2023 & 2031 (%)

Figure 34 North America Hazardous Drug Administration Market Share, By Drug Type, 2023 & 2031 (%)

Figure 35 North America Hazardous Drug Administration Market Share, By Devices, 2023 & 2031 (%)

Figure 36 North America Hazardous Drug Administration Market Share, By Drug Form, 2023 & 2031 (%)

Figure 37 North America Hazardous Drug Administration Market Share, By Perfusion Pressure, 2023 & 2031 (%)

Figure 38 North America Hazardous Drug Administration Market Share, By Country, 2023 & 2031 (%)

Figure 39 South America Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 40 South America Hazardous Drug Administration Market Share, By Systems, 2023 & 2031 (%)

Figure 41 South America Hazardous Drug Administration Market Share, By Drug Type, 2023 & 2031 (%)

Figure 42 South America Hazardous Drug Administration Market Share, By Devices, 2023 & 2031 (%)

Figure 43 South America Hazardous Drug Administration Market Share, By Drug Form, 2023 & 2031 (%)

Figure 44 South America Hazardous Drug Administration Market Share, By Perfusion Pressure, 2023 & 2031 (%)

Figure 45 South America Hazardous Drug Administration Market Share, By Country, 2023 & 2031 (%)

Figure 46 Europe Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 47 Europe Hazardous Drug Administration Market Share, By Systems, 2023 & 2031 (%)

Figure 48 Europe Hazardous Drug Administration Market Share, By Drug Type, 2023 & 2031 (%)

Figure 49 Europe Hazardous Drug Administration Market Share, By Devices, 2023 & 2031 (%)

Figure 50 Europe Hazardous Drug Administration Market Share, By Drug Form, 2023 & 2031 (%)

Figure 51 Europe Hazardous Drug Administration Market Share, By Perfusion Pressure, 2023 & 2031 (%)

Figure 52 Europe Hazardous Drug Administration Market Share, By Country, 2023 & 2031 (%)

Figure 53 Asia-Pacific Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 54 Asia-Pacific Hazardous Drug Administration Market Share, By Systems, 2023 & 2031 (%)

Figure 55 Asia-Pacific Hazardous Drug Administration Market Share, By Drug Type, 2023 & 2031 (%)

Figure 56 Asia-Pacific Hazardous Drug Administration Market Share, By Devices, 2023 & 2031 (%)

Figure 57 Asia-Pacific Hazardous Drug Administration Market Share, By Drug Form, 2023 & 2031 (%)

Figure 58 Asia-Pacific Hazardous Drug Administration Market Share, By Perfusion Pressure, 2023 & 2031 (%)

Figure 59 Asia-Pacific Hazardous Drug Administration Market Share, By Country, 2023 & 2031 (%)

Figure 60 Middle East & Africa Hazardous Drug Administration Market Value, 2022-2031 (US$ Million)

Figure 61 Middle East & Africa Hazardous Drug Administration Market Share, By Systems, 2023 & 2031 (%)

Figure 62 Middle East & Africa Hazardous Drug Administration Market Share, By Drug Type, 2023 & 2031 (%)

Figure 63 Middle East & Africa Hazardous Drug Administration Market Share, By Devices, 2023 & 2031 (%)

Figure 64 Middle East & Africa Hazardous Drug Administration Market Share, By Drug Form, 2023 & 2031 (%)

Figure 65 Middle East & Africa Hazardous Drug Administration Market Share, By Perfusion Pressure, 2023 & 2031 (%)

Figure 66 ICU Medical : Financials

Figure 67 Equashield, LLC: Financials

Figure 68 Simplivia Healthcare Ltd. : Financials

Figure 69 Becton & Dickinson : Financials

Figure 70 Baxter International: Financials

Figure 71 Vygon SAS : Financials

Figure 72 JMS Co., Ltd. : Financials

Figure 73 B. Braun Medical Inc. : Financials

Figure 74 Yukon Medical: Financials

Figure 75 Codan Medical: Financials

세계 위험 약물 투여 시장 – 2024-2031

Global Hazardous Drug Administration Market - 2024-2031